Itulazax

Betula verrucosa, the active ingredient in Itulazax, is a allergen immunotherapy presented as a sublingual preparation for sublingual use. It treats birch pollen allergy, allergic rhinitis and allergic conjunctivitis in patients with sensitization to Betula verrucosa. GNH USA supplies Itulazax as a licensed, GDP-compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Itulazax is used in allergen immunotherapy to modify immune response to birch pollen and related allergic conditions. - Birch pollen allergy: reduces symptom severity and promotes long‑term tolerance. - Allergic rhinitis: decreases nasal congestion, sneezing and itching. - Allergic conjunctivitis: lessens eye redness, itching and tearing.

Adverse reactions may occur with sublingual immunotherapy and are categorized by frequency.

Common Side Effects: - Oral itching or tingling. - Mild throat irritation. - Transient mouth edema. - Nausea. - Headache. - Altered taste perception.

Serious or Rare Side Effects: - Anaphylaxis. - Severe oral swelling. - Bronchospasm. - Systemic allergic reaction. - Urticaria. - Angioedema.

Before prescribing Itulazax, clinicians should consider specific safety aspects. - Pregnancy: safety not established; evaluate risk‑benefit. - Breastfeeding: unknown; use only if benefits outweigh risks. - Concurrent immunotherapy: monitor for additive immune reactions. - Severe asthma: administer with caution; may exacerbate symptoms. - Medication adherence: follow prescriber instructions closely. - Store at room temperature: keep in original container, protect from moisture and direct sunlight.

Itulazax may interact with other medicines; interactions are grouped by clinical relevance.

Major Interactions (Avoid): - Beta‑blockers: may mask signs of anaphylaxis. - ACE inhibitors: increase risk of angioedema. - Other allergen immunotherapies: may potentiate immune response.

Moderate Interactions (Monitor Closely): - Antihistamines: may reduce sublingual immunotherapy efficacy. - Corticosteroids: could alter immune modulation. - Immunosuppressants: may diminish therapeutic effect.